Close
Nordic 9Nordic 9

Bristol-Myers Squibb (investor - Corporate Investor)

United States
See something wrong or missing? Let us know
Average round investment:65.65M USD
Average number per year:1.8
Distribution: 2024 (2)2023 (1)2022 (1)2021 (3)2020 (2)
Portfolio companies: United Kingdom NeoPhoreUnited Kingdom Pathios TherapeuticsUnited Kingdom AstronauTx See the entire list
Mostly invests in: United Kingdom United Kingdom (5) Health services (9)
See the entire list

Showing 3 of 9 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Bristol-Myers Squibb mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Bristol-Myers Squibb

Name Criteria
United States Honeywell Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Denmark Maj Invest
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Mayfair Equity Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Polaris Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany, Denmark
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Research Corporation Technologies
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Patient Square Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom 3i
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany, Denmark
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Switzerland HBM Healthcare Investments
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany, Denmark
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States What If Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Kairos
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Top